Trauma, Psychedelics, and Why Therapy Is the Conversation No One Finishes

THERAPY TOPICS • July 8, 2025

Back in the Kitchen

Rachel blinks, the fluorescent lights of her apartment kitchen a harsh contrast to the kaleidoscopic journey she’s just returned from. The lingering warmth of the blanket she’d wrapped herself in during the ketamine session still clings to her, a faint echo of the profound sense of connection she’d felt just an hour ago. Now, the silence of her apartment feels vast, almost cavernous.

She picks up her phone, the cool glass a familiar weight in her hand, and scrolls aimlessly through social media. A friend’s vacation photos, a news headline about the latest tech innovation, an ad for a new biohacking supplement. None of it lands. The profound insights, the emotional release, the feeling of being utterly unbound — it all feels distant, already fading into the mundane. A quiet ache settles in her chest. She’s back, but where exactly is “here” now?

The world outside her window continues, indifferent to the inner revolution she’s just experienced. She feels a profound sense of isolation, a disconnect between the vastness of her internal landscape and the small, contained reality of her living room. The experience was powerful, transformative even — but now what? The question hangs in the air, unanswered, as she continues to scroll, searching for something, anything, to bridge the gap.

This isn’t an uncommon scenario. In my work with clients, I’ve seen this exact moment play out in countless variations. The profound experience of a psychedelic journey can crack open the rigid defenses we’ve built around our trauma. It can offer glimpses of a different way of being, a sense of interconnectedness, and a release from long-held emotional burdens. But without a skilled hand to help integrate these experiences, the profound insights can become just another unmoored memory — another powerful experience that doesn’t quite translate into sustainable change. It’s a conversation that’s been started, but one that she desperately needs help finishing.

This post exists at the intersection of two things I care deeply about: the extraordinary promise of psychedelic-assisted therapy for trauma, and the critical importance of the therapeutic relationship in realizing that promise. If you’re new to the broader context of how trauma drives chronic suffering in driven women, the anchor piece on the stress behind the stress provides the neurobiological foundation.

What Psychedelic Therapy Is Actually Doing Neurobiologically

In my work with clients, I’ve seen a growing curiosity about psychedelic-assisted therapy. It’s not just a trend; it’s a profound shift in how we approach mental health, particularly trauma. To understand why, we need to look at what’s happening in the brain when someone engages with these medicines. It’s not magic; it’s neurobiology.

At the heart of it, psychedelics like psilocybin, MDMA, and ketamine seem to temporarily quiet the Default Mode Network. Think of the DMN as your brain’s autopilot — the neural network responsible for self-referential thought, rumination, and maintaining your sense of self. It’s where our ego resides, where we replay past events, and worry about the future. For many driven women, this DMN is often in overdrive, constantly analyzing, planning, and self-critiquing. When the DMN is temporarily subdued, it creates a window of opportunity — a temporary liberation from the tyranny of the self-critical mind.

This window allows for what neuroscientists call a neuroplasticity window. Dr. Robin Carhart-Harris, PhD, a neuroscientist at UCSF and a pioneering psychedelic researcher, has extensively studied these effects. His work suggests that by disrupting rigid thought patterns, particularly those associated with the DMN, psychedelics can help individuals break free from entrenched ways of thinking and feeling, especially those linked to trauma. This isn’t about erasing memories, but about altering the emotional charge and narrative surrounding them — creating new neural pathways that bypass the old, well-worn grooves of fear and pain.

During this neuroplastic window, the brain becomes more open to new perspectives and experiences. It’s like hitting the reset button on a deeply ingrained operating system, allowing for a fresh installation of healthier patterns. The temporary dissolution of ego boundaries can foster a sense of interconnectedness and compassion — both for oneself and for others — which is often a profound corrective experience for individuals who have felt isolated by their trauma.

Why the Molecule Without the Relationship Is Not Enough

It’s tempting to view psychedelics as a quick fix — a magic pill that can instantly resolve deep-seated trauma. But in my clinical experience, and as the science clearly shows, the molecule itself is only one part of a much larger, more intricate process. Without the right container, without the skilled guidance of a therapist, the profound experiences catalyzed by psychedelics can be disorienting, even destabilizing. They can, in fact, retraumatize an individual if not handled with immense care and expertise.

Think of it this way: the psychedelic experience opens a door, but it doesn’t automatically lead you through it. It’s a powerful catalyst for change, creating a temporary state of psychological flexibility. This is where integration becomes paramount. Integration isn’t just talking about your trip; it’s the active, ongoing process of making sense of the insights gained during a psychedelic session and weaving them into your daily life. It’s about translating the profound, often ineffable, experiences into tangible shifts in behavior, thought patterns, and relational dynamics.

Rick Doblin, PhD, founder and President of MAPS (Multidisciplinary Association for Psychedelic Studies), has been a tireless advocate for psychedelic-assisted therapy, emphasizing the critical role of psychotherapy in maximizing therapeutic outcomes. His work, and the extensive research conducted by MAPS, consistently demonstrates that the efficacy of psychedelics for conditions like PTSD is significantly enhanced when administered within a carefully structured therapeutic framework. It’s the relationship with the therapist that provides the safety, the interpretation, and the scaffolding needed to navigate these altered states and integrate their lessons.

Without this crucial step, individuals can be left feeling overwhelmed, confused, or even more disconnected than before. The brain might be more plastic, more open to new pathways, but without intentional guidance, those new pathways might not lead to lasting healing. In my practice, I’ve seen how vital this ongoing conversation is; it’s where the real, sustainable change takes root. The medicine opens the door, but the therapist walks through it with you, helping you to furnish the new room and make it your own.

The Unmoored Journey: A Vignette

In my practice, I’ve seen women, driven and ambitious, who’ve sought out psychedelic experiences with the best intentions. Take Monica. She’s a brilliant architect, accustomed to meticulously planning every detail of her life. She’d read Michael Pollan’s How to Change Your Mind and felt a deep resonance with the potential for healing that psychedelics offered. She booked herself into a week-long retreat in a beautiful, remote location, hoping to finally address the persistent anxiety and a sense of emotional numbness that had shadowed her for years, despite her outward success.

Monica’s experience at the retreat was, by her own account, profoundly transformative. She described vivid visions, a feeling of interconnectedness with all living things, and moments of intense emotional release where she felt she was finally letting go of old hurts. She left feeling like a new person, ready to embrace life with renewed vigor, convinced she had finally found the key to unlocking her deepest wounds.

But then she came home. The vibrant colors of her psychedelic journey faded into the muted tones of her everyday life. The profound insights she’d gained felt increasingly abstract, difficult to translate into her demanding work schedule, her sometimes-strained relationship with her partner, and the subtle, yet persistent, triggers of her past. She found herself trying to explain her experience to well-meaning friends who simply couldn’t grasp the depth of it.

She’d try to meditate, to journal, to revisit the feelings of peace and clarity, but the mundane pressures of life would quickly pull her back into old patterns. The neuroplasticity window, which had felt so wide open during the retreat, seemed to be closing. The old neural pathways, deeply etched by years of adaptive coping mechanisms, began to reassert themselves. Without a consistent, skilled guide to help her process the raw material of her experience, Monica felt herself slowly drifting back to where she started.

The profound experience became a beautiful, but ultimately unintegrated, memory. It wasn’t that the medicine didn’t work; it was that the conversation it started had no one to finish it with her. This is what I see consistently: the molecule can open the door, but it’s the ongoing relational work that helps you walk through it and truly inhabit the new space. Monica’s story isn’t a failure of the medicine — it’s a testament to the critical need for robust, ongoing therapeutic support. For women with the attachment and trauma patterns described in our post on why driven women are the hardest nervous systems to heal, the integration work is especially non-negotiable.

What Skilled Psychedelic-Assisted Therapy Actually Looks Like

When we talk about skilled psychedelic-assisted therapy, we’re not talking about a passive experience where a client takes a substance and the therapist simply observes. In my work, I’ve seen that the therapist’s role is profoundly active, engaged, and crucial at every stage of the process.

Before any medicine is administered, there’s a significant period of preparation. This involves building rapport, establishing clear intentions for the session, and educating the client about what to expect. We explore their history, their traumas, and their goals for healing. This preparatory phase is vital; it helps to create a sense of safety and psychological readiness, which can profoundly influence the psychedelic experience itself. It’s about setting the stage for deep work, ensuring the client feels held and understood before they even enter an altered state. This is where the therapeutic alliance — the bedrock of all effective therapy — is forged.

During the psychedelic session, the therapist acts as a compassionate guide and anchor. They’re not directing the experience, but rather holding a safe and supportive container. Bessel van der Kolk, MD, author of The Body Keeps the Score and one of the world’s foremost trauma researchers, emphasizes the importance of a felt sense of safety in healing trauma. In psychedelic therapy, the therapist’s presence helps to cultivate this safety, allowing the client to explore difficult emotions and memories without being overwhelmed. They are a steady presence in what can often feel like a turbulent internal landscape — a lighthouse guiding the client through the storm.

After the session, the integration work begins in earnest. This is where the therapist’s expertise in relational trauma and psychotherapeutic techniques truly shines. We help clients process the insights they’ve gained, explore the emotions that arose, and connect these experiences to their everyday lives. This can involve various modalities — somatic experiencing, cognitive restructuring, IFS work — all aimed at helping the client weave their psychedelic journey into a coherent narrative of healing and growth.

Dr. Gabor Maté, MD, physician and trauma and addiction expert and author of When the Body Says No, often speaks about the need to understand the root causes of suffering. In psychedelic integration, we delve into these roots, using the openness created by the medicine to foster profound self-compassion and understanding. This is a sustained conversation, often spanning many sessions, that helps solidify the gains and prevent the insights from fading away.

You can explore the specific clinical framework for this work in our dedicated posts on psychedelic integration therapy and ketamine-assisted psychotherapy — both written specifically for driven, ambitious women navigating this territory.

Both/And: The Medicine Matters AND the Therapy Matters

In the evolving landscape of mental health, it’s easy to fall into an either/or trap. Is it the medicine that heals, or is it the therapy? In my clinical experience, and what the emerging research consistently shows, it’s unequivocally both. Psychedelics are not a replacement for therapy; they are a powerful adjunct — a catalyst that can accelerate and deepen the therapeutic process. The future of trauma treatment isn’t medicine or therapy; it’s medicine within therapy.

The psychedelic compounds themselves — whether it’s MDMA, psilocybin, or ketamine — offer unique pharmacological actions that can facilitate healing. They can reduce defensiveness, enhance emotional processing, and foster a sense of connection and insight that might be difficult to access in conventional therapy alone. Dr. Franz Vollenweider, MD, a psychiatrist at the University of Zurich, has conducted extensive research on the neurobiological effects of psychedelics, highlighting their capacity to induce states of consciousness that can be profoundly therapeutic when properly guided.

However, this openness, this neuroplasticity, is a double-edged sword. Without the skilled guidance of a therapist, without the relational container, the insights gained can remain unintegrated, leading to confusion, distress, or even retraumatization. It’s the therapist who helps to connect the dots between the profound insights of a psychedelic journey and the client’s lived experience, their relational patterns, and their core beliefs about themselves and the world.

What I see consistently in my therapy room is that the medicine can open the door to healing, but it’s the ongoing therapeutic relationship that helps clients walk through it and build a new, more resilient foundation. It’s the consistent, compassionate presence of another human being that teaches the nervous system that safety is possible, that vulnerability can be met with acceptance, and that deep, lasting change is achievable.

The medicine provides the push, but the therapy provides the direction, the integration, and the sustained support needed to truly transform trauma into growth. It’s a powerful synergy, where the whole is far greater than the sum of its parts. This understanding of why therapy is the irreplaceable container connects directly to the broader framework in the stress behind the stress — the argument that the therapeutic relationship is not peripheral to women’s health but upstream of everything else.

The Systemic Lens: The “One and Done” Narrative and Industry Incentives

It’s crucial to look at the broader context surrounding the psychedelic renaissance, particularly the systemic forces at play. While the therapeutic potential of these medicines is undeniable, there’s a growing concern in the clinical community about how psychedelics are being marketed and perceived by the public. The narrative of a “one and done” cure — a single psychedelic journey that magically resolves all trauma — is not only inaccurate but also deeply dangerous. It’s a narrative that often overlooks the complex, relational nature of healing, reducing a profound process to a simplistic transaction.

This oversimplification isn’t accidental; it’s often driven by the incentives of the emerging psychedelic industry. As psychedelics move closer to mainstream medical acceptance, venture capital and profit motives are entering the space. It’s easier to market a quick solution, a revolutionary pill, than it is to advocate for the slow, often arduous, and deeply personal work of psychotherapy. The return on investment for a single dose of medicine is far more appealing to investors than the long-term, relational commitment required for true integration.

In my work, I’ve seen how this marketing can create unrealistic expectations for clients. They come in hoping for an instant cure, only to find that while the experience itself might be profound, the real work of integration still lies ahead. This can lead to disappointment, frustration, and a sense of failure if they don’t immediately feel “fixed.” It’s a disservice to the client and to the medicine itself.

Michael Pollan, in his influential book How to Change Your Mind, explores the history and potential of psychedelics — but also implicitly highlights the need for careful stewardship and ethical frameworks as these substances re-enter society. He doesn’t present them as a panacea, but as powerful tools that require respect and proper guidance. The popularization of psychedelics, while increasing access, also necessitates a robust ethical framework to ensure that the healing potential is not overshadowed by commercial interests.

Furthermore, the current medical model often struggles with anything that doesn’t fit neatly into a diagnostic category or a prescribed treatment protocol. The relational, experiential, and deeply subjective nature of psychedelic therapy doesn’t always align with existing healthcare structures. We must be vigilant in advocating for a model that prioritizes holistic healing, recognizing that the molecule is a key — but not the entire — solution.

What Meaningful Access and Healing Look Like

What does meaningful access to psychedelic healing truly look like? It’s not about quick fixes or isolated experiences. It’s about creating comprehensive, compassionate systems that honor the depth and complexity of trauma. It’s about recognizing that the profound insights offered by psychedelics are just the beginning, not the end, of the healing journey.

Meaningful access means prioritizing preparation and integration as much as, if not more than, the psychedelic session itself. It means training a new generation of clinicians who are not only skilled in psychedelic facilitation but also deeply rooted in relational trauma work — therapists who understand the nuances of attachment, the complexities of the nervous system, and the profound importance of a consistent, trusting relationship.

Imagine a future where a driven woman, carrying the weight of past traumas, can access psychedelic-assisted therapy not as a last resort, but as a deeply supported path to wholeness. She’s not left alone to grapple with overwhelming insights; instead, she’s guided by a therapist who helps her weave those insights into a new narrative of self-compassion and resilience. She learns to understand her nervous system, to regulate her emotions, and to build secure attachments — not just with her therapist, but in all her relationships.

This vision of healing is communal. It recognizes that we heal in relationship, not in isolation. It’s a future where the conversation about trauma and healing isn’t just started by a powerful molecule, but is nurtured and completed within the safety of a therapeutic relationship. The profound internal shifts demand an equally profound external container — a relational space where the new self can be nurtured and understood, not just experienced in isolation.

The women who truly thrive after engaging with psychedelics are those who commit to the ongoing work of therapy. They understand that the medicine is a powerful tool, but the real alchemy happens in the sustained, relational space of the therapeutic encounter. This commitment to integration is what transforms a powerful experience into lasting healing — a conversation that, when truly finished, leads to profound and sustainable transformation.

If you’re exploring psychedelic-assisted therapy or ketamine-assisted psychotherapy, the posts on psychedelic integration therapy and KAP for ambitious women provide specific clinical detail. Individual therapy and a complimentary consultation are available for women ready to build the container for this work. The C-PTSD post provides important context for understanding the complexity of trauma that psychedelic therapy is often being asked to address. And the Strong & Stable newsletter is where this conversation continues every Sunday — with the nuance and depth that the topic deserves.

Related Reading

Carhart-Harris, Robin L., and Karl J. Friston. “REBUS and the Anarchic Brain: Toward a Unified Framework for the Action of Psychedelics.” Pharmacological Reviews 71, no. 3 (2019): 316–344.

Pollan, Michael. How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. New York: Penguin Press, 2018.

van der Kolk, Bessel A. The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. New York: Viking, 2014.

Vollenweider, Franz X., and Michael Kometer. “The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Psychiatric Disorders.” Nature Reviews Neuroscience 11, no. 9 (2010): 642–651.

Maté, Gabor. When the Body Says No: Understanding the Stress-Disease Connection. Hoboken, NJ: John Wiley & Sons, 2011.

Kryskow, Pamela, et al. “Psychedelic-Assisted Psychotherapy: A New Paradigm for Mental Health Care.” Canadian Medical Association Journal 194, no. 1 (2022): E1–E2.

Medical Disclaimer

Medical Disclaimer